Elif Duygu Topan

Elif Duygu Topan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAli Kirik
Ali Kirik
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
Nizameddin KocaNizameddin Koca
Nizameddin Koca
TKTurkan Pasali Kilit
Turkan Pasali Kilit
SSsibel demiral sezer
sibel demiral sezer
TDTeoman Doğru
Teoman Doğru
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence data in Türkiye is limited. We aimed to determine the nationwide prevalence of MASLD and advanced hepatic fibrosis risk in subjects with cardiometabolic risk factors (CMRF). Despite recent international consensus redefining fatty liver disease terminology, no nationwide MASLD study has been reported in Türkiye. Methods: This cross-sectional study included 14,371 adults with ≥1 CMRF from 44 centers across 31 cities. MASLD was diagnosed using liver ultrasonography plus cardiometabolic criteria. Advanced fibrosis risk was assessed by fibrosis-4 (FIB-4) score (≥1.3 for ≤65 years; ≥2.0 for >65 years). Logistic regression was used to identify independent predictors of high FIB-4. Results: A total of 61.4% of participants were women, the mean age was 51.3 ± 14.4 years, and the mean BMI was 31.4 ± 6.0 kg/m2. MASLD prevalence was 75.7% (n = 10,873), rising with the number of CMRFs (56.5% with one factor vs. 83.4% with all). The prevalence of high FIB-4 scores was 12.0% overall, being lower in MASLD patients than non-MASLD patients (11.2% vs. 14.4%, p < 0.001). FIB-4 scores decreased with increasing BMI (28.1% underweight vs. 8.7% class III obesity). Male sex, T2DM, and hypertension independently predicted high FIB-4 scores, while smoking, higher BMI, and MASLD were inversely associated. Conclusions: Three-quarters of Turkish adults with CMRF have MASLD. Standard FIB-4 thresholds may underestimate fibrosis risk in obese and smoking populations, underscoring the need for adjusted cut-offs or alternative tools. This study is the first to provide nationwide MASLD prevalence data in Türkiye.

17 April 2026 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Closed access
HUHilal Bektaş Uysal
Hilal Bektaş Uysal
HBHüseyin Bayğın
Hüseyin Bayğın
ETElif Duygu Topan
Elif Duygu Topan
MYMustafa Yılmaz
Mustafa Yılmaz
Purpose: Metabolic syndrome (MetS) is a growing public health problem characterized by clustering of cardiometabolic risk factors and a chronic low-grade inflammatory state. Biomarkers such as Fetuin-A, YKL-40, and high-sensitivity C-reactive protein (hsCRP) have been implicated in insulin resistance, obesity, and atherosclerosis. Identifying accessible and cost-effective biomarkers that reflect the presence and severity of MetS may provide clinically relevant insight into metabolic burden. Therefore, this study aimed to evaluate whether inflammatory biomarkers are associated with the presence and dynamic severity of MetS. Methods: Forty-seven patients diagnosed with MetS according to National Cholesterol Education Program Adult Treatment Panel III criteria (≥3 components) and 23 healthy controls were included. Serum hsCRP, Fetuin-A, and YKL-40 levels were measured at baseline and after a 3-month follow-up. No pharmacological treatment was initiated; participants received standardized lifestyle modification advice. Associations between biomarker levels and MetS severity scores (range 3–5) were assessed using correlation analyses. Results: Baseline serum Fetuin-A, YKL-40, and hsCRP levels were significantly higher in patients with MetS compared to controls (all P < 0.001). During follow-up, changes in MetS severity were positively correlated with changes in hsCRP (r = 0.844, P < 0.001), Fetuin-A (r = 0.918, P < 0.001), and YKL-40 (r = 0.913, P < 0.001). Sensitivity analysis using Kendall’s tau-b confirmed robust monotonic associations (τ = 0.716–0.808, all P < 0.001). Conclusion: Fetuin-A and YKL-40 levels are strongly associated with both the presence and short-term changes in MetS severity. hsCRP appears to reflect longitudinal changes in metabolic burden. These findings suggest that selected inflammatory biomarkers may provide additional insight into the inflammatory and metabolic dynamics of MetS.

2 January 2026 in Postgraduate Medicine
Verified
Journal Article
Closed access
BTBurcin Atak Tel
Burcin Atak Tel
İBİfakat İrem Biçer
İfakat İrem Biçer
IBIsil Bavunoglu
Isil Bavunoglu
NONur Düzen Oflas
Nur Düzen Oflas
MTMelisa Sahin Tekin
Melisa Sahin Tekin
SKSelma Karaahmetoglu
Selma Karaahmetoglu
Hashimoto's thyroiditis (HT) is a T-cell mediated autoimmune disease characterized by the progressive destruction of thyroid gland. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score and systemic inflammatory index (SII) are novel markers of inflammation. We aimed to compare HALP score and SII values of patients with HT to those in healthy control subjects in the present study. Patients diagnosed with HT and healthy volunteers (as controls) were included in the study. The SII and HALP score were calculated using the following formulas: SII = (Platelet count×Neutrophil count)/Lymphocyte count. HALP score = (Hemoglobin×Serum Albumin×Lymphocyte count)/Platelet count. SII and HALP score of patients with HT and healthy controls were compared. Median SII of the patients with HT (510 (140-3646)) was significantly higher than that of the control subjects (422 (102-2173)) (p < 0.001). Median HALP score of the HT group (47 (7-149)) was significantly lower than that of the control group (54 (10-160)) (p < 0.001). The sensitivity and specificity of SII (when higher than 452%) in detecting HT were 61% and 62%, respectively (AUC: 0.64, p < 0.001, 95%CI: 0.61-0.67). A HALP score lower than 49.5% threshold had 64% sensitivity and 57% specificity in detecting HT (AUC: 0.61, p < 0.001, 95%CI: 0.57-0.64). In logistic regression analysis (considering age, gender, eGFR, TSH, CRP, ESR, BMI), a unit increase in SII increased the risk of HT by 0.3% (p < 0.001, OR: 1.003, 95%CI: 1.002-1.004). HALP score was also an independent risk factor for HT. A unit increase in HALP score decreased the risk of HT by 2% (p < 0.001, OR: 0.977, 95%CI: 0.968-0.985). We recommend that, due to their inexpensive and easily assessable nature, SII and HALP score could serve as additional diagnostic tools in HT.

26 October 2026 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
ETElif Duygu Topan
Elif Duygu Topan
IÖİmRan Kurt Ömürlü
İmRan Kurt Ömürlü
HUHilal Bektas Uysal
Hilal Bektas Uysal
Background: Accurate prognostic assessment is essential in palliative care to support treatment planning, goal setting, and communication with patients and families. Although functional status, comorbidity burden, and routinely available laboratory indices have each been associated with prognosis, evidence regarding their simultaneous prognostic contribution in real-world palliative care populations including both malignant and non-malignant patients remains limited. This study primarily evaluated the associations of Eastern Cooperative Oncology Group performance status (ECOG PS), Charlson Comorbidity Index (CCI), Prognostic Nutritional Index (PNI), and neutrophil-to-lymphocyte ratio (NLR) with overall survival (OS) in a mixed inpatient palliative care cohort. Secondary objectives included evaluating 30-day mortality and examining prognostic associations separately in malignant and non-malignant subgroups. Methods: This retrospective single-centre cohort included 260 consecutive eligible adults admitted to the palliative care unit between August 2023 and September 2025. Clinical, laboratory, and outcome data were obtained from medical records. Overall survival was assessed using multivariable Cox proportional hazards regression, and 30-day mortality using multivariable logistic regression. Receiver operating characteristic analysis evaluated the discriminative performance of CCI, PNI, and NLR. Analyses were performed for the overall cohort and malignant and non-malignant subgroups. Results: Of 260 patients, 156 (60.0%) had malignant disease and 104 (40.0%) had non-malignant disease. In the overall cohort, ECOG PS, CCI, PNI, and NLR were independently associated with overall survival, whereas ECOG PS, CCI, and NLR were independently associated with 30-day mortality. In subgroup analyses, PNI was associated with OS in non-malignant but not malignant patients and with 30-day mortality only in non-malignant patients, whereas NLR remained associated with both outcomes in both subgroups. NLR had the highest observed area under the curve for 30-day mortality in the overall cohort (0.745; 95% confidence interval, 0.687–0.796) and an area under the curve of 0.776 (95% confidence interval, 0.683–0.852) in the non-malignant subgroup. Conclusions: Functional status, comorbidity burden, and routinely available laboratory indices were associated with prognosis in palliative care patients. NLR showed the highest observed discrimination for 30-day mortality and remained associated with both outcomes in malignant and non-malignant subgroups. PNI was associated with OS in the overall cohort and the non-malignant subgroup and with 30-day mortality only in the non-malignant subgroup.

11 September 2026 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
ETElif Duygu Topan
Elif Duygu Topan
AVAral Varol
Aral Varol
HUHilal Bektas Uysal
Hilal Bektas Uysal
IÖİmRan Kurt Ömürlü
İmRan Kurt Ömürlü
MGMustafa Gok
Mustafa Gok
Background: Metabolic syndrome (MetS) is associated with increased cardiovascular risk, which rises with the number of MetS components. Conventional carotid ultrasound markers may not fully characterize dynamic arterial wall mechanics, whereas speckle-tracking carotid strain ultrasonography (STCS-US) enables integrated assessment of carotid stiffness and deformation throughout the cardiac cycle. This study aimed to assess multidimensional carotid mechanics in individuals with MetS and their association with cumulative metabolic burden. Methods: This retrospective cross-sectional study included 100 participants:50 patients with MetS diagnosed according to the National Cholesterol Education ProgramAdult Treatment Panel III (ATP III) criteria and 50 age and sex matched controls without MetS Carotid Doppler US images were analyzed using the Arterial Analysis software program, which quantified 22 vascular parameters per participant, comprising five stiffness parameters (β-stiffness index [β-SI], arterial compliance [AC], arterial distensibility [AD], elastic modulus [EM], and pulse wave velocity [PWV]) and six strain parameters (radial strain, radial displacement [DP], radial strain rate [SR], circumferential strain, circumferential displacement, and circumferential strain rate), each obtained in both the longitudinal and transverse planes. Correlations between the number of MetS components and imaging-derived vascular parameters were analyzed. Classification and Regression Trees (CART) analysis was performed to evaluate the relative contribution of clinical and structural variables to STCS-US-derived vascular parameters. Results: Patients with MetS exhibited significantly increased stiffness parameters, including EM and PWV, and reduced compliance indices compared with controls (all p < 0.05). Strain analysis demonstrated significantly lower radial and circumferential strain percentages in the MetS group, with more pronounced alterations observed in the transverse plane (all p < 0.001). Increasing MetS component count was associated with higher stiffness indices and lower strain values. CART analysis demonstrated that MetS status remained one of the most important determinants across the reported STCS-US-derived vascular parameters. Conclusion: STCS-US revealed coordinated impairment in carotid arterial stiffness and strain parameters in MetS, particularly in the transverse plane. These findings suggest that STCS-US may provide complementary functional information alongside conventional stiffness assessment and may reflect the cumulative metabolic burden on vascular mechanics.

4 February 2026 in European Journal of Medical Case Reports
Verified
Journal Article
Closed access
ETElif Duygu Topan
Elif Duygu Topan
HUHilal Bektas Uysal
Hilal Bektas Uysal
Background: Wolfram syndrome type 1 is a rare, autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is classically characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness, but its clinical spectrum is highly heterogeneous. Delayed recognition is common, especially when features are misattributed to diabetes complications. Case Report: We present a 39-year-old man with insulin-dependent diabetes mellitus since adolescence, who developed progressive multisystem involvement including optic atrophy, neurogenic bladder with end-stage renal disease, psychiatric manifestations, and neurological complications. Despite early diabetes onset, Wolfram syndrome was not suspected until late in the disease course. Genetic analysis revealed a homozygous missense variant in WFS1 (c.1672C>T; p.Arg558Cys), previously described as a founder mutation and classified as pathogenic according to the criteria of the American College of Medical Genetics and Genomics. The patient exhibited an incomplete phenotype, with optic atrophy and suspected central diabetes insipidus, but without documented sensorineural hearing loss. Despite multidisciplinary supportive care, the disease followed a relentlessly progressive course and the patient died due to multisystem failure. Conclusion: This case highlights the diagnostic challenges of Wolfram syndrome in adulthood, where overlapping features with diabetic complications may obscure recognition. Early genetic testing in patients with juvenile-onset diabetes and optic atrophy is critical for timely diagnosis, comprehensive surveillance, and appropriate counseling. Reporting adult-onset cases with founder variants contributes to expanding the clinical spectrum and emphasizes the importance of multidisciplinary management in this rare but devastating disorder.